Abstract:BACKGROUND: Of the many growth factors that can enhance bone formation, the bone morphogenic proteins (BMPs) are probably the most effective and most widely studied for applications requiring new bone growth. To analyze the effects, the gold standard is patient randomized control trials, however, only BMP-2 and BMP-7 have reached this level of investigation. OBJECTIVE: In this meta analysis the recent findings concerning the application of recombinant human bone morphogenic protein-2 (rhBMP-2) in tissue engineering and gene therapy, the options of its transfer means, as well as the ideal time of delivery is discussed. RETRIEVAL STRATEGY: The relevant articles published between January 1997 and December 2006 were searched for in Pubmed database by researcher of this article with the key words "recombinant human bone morphogenic proteins (rhBMPs), tissue engineering, gene therapy" in English. A total of 81 articles were selected and reviewed by the standards of: ① Having close relations with the application of rhBMP-2 in tissue engineering and gene therapy; ② The most recently published articles and articles in authority journals were chosen in the same field. Exclusion criteria: repetitive studies. LITERATURE EVALUATION: The main sources of literature are the application of rhBMP-2 in tissue engineering and gene therapy. Among the 52 selected articles, 12 are reviews or meeting reports, others are clinical or elementary experimental studies. DATA SYNTHESIS: BMPs are members of the TGF-β superfamily, which are released by osteoprogenitor cells and typically improve bone growth. The use of scaffolds, cells, and growth factors for bone regeneration is called bone tissue engineering. The application of rhBMP-2 in tissue engineering holds great promise for the augmentation and manipulation of bone and soft tissue repair. One potential alternative to direct rhBMP-2 delivery is to develop a biologic cellular delivery vehicle via gene therapy to enhance bone formation. The application of rhBMP-2 in gene therapy holds great promise for the augmentation and manipulation of bone and soft tissue repair. The research indicated that the dosing, time, and transfer mode of rhBMP-2 to the desired targets remain a facing challenge. Further studies should focus on the ideal dosing, time and method of delivery, which should be easily and reliably displayed, cost effective, and clearly controlled. CONCLUSION: The future of bone and soft tissue repair will likely be based on biologic augmentation of healing and tissue regeneration. The use of rhBMP-2 holds great promise for the augmentation and manipulation in tissue engineering and gene therapy.

Research Progress of BMP-2 Gene Therapy for Bone Defect

Evaluation of Bone Regeneration by Β Tricalcium Phosphate/Collagen Scaffold Loaded with Bone Morphogenetic Proteins 2 Plasmid in Rat Cranial Defect

Studies on Recombinant Human Bone Morphogenetic Protein 2 Loaded Nano-Hydroxyapatite/Silk Fibroin Scaffolds

BMP-2 Gene Delivery-Based Bone Regeneration in Dentistry

[Effects of BMP-2 Gene Therapy on Vascularization in Repairing Bone Defects].

Recombinant human bone morphogenic protein-2 in tissue engineering and gene therapy

Repair of Bone Injury and Osteonecrosis with BMP2 Gene Therapy and Stem Cell Transplantation

Research progress of gene therapy combined with tissue engineering to promote bone regeneration

Research progress and clinical application of repairing bone defects using tissue engineered bone

Particle gun-mediated bone morphogenetic protein-2 gene transfection for treatment of chronic bone defects

The effects of BMP-2 gene medication on the reconstruction of osteolytic bone defect around implant

Advances in the application of bone morphogenetic proteins and their derived peptides in bone defect repair

[Direct Bone Morphogenetic Protein 2 Gene Therapy for Repairing Segmental Radial Defect in Rabbits].

Function and clinical applications of bone morphogenetic proteins in bone repair

Study on the Bone Morphogenetic Protein 2 Loaded Synergistic Hierarchical Porous Silk/carbon Nanocage Scaffold for the Repair of Bone Defect

Autografts and xenografts of skin fibroblasts delivering BMP-2 effectively promote orthotopic and ectopic osteogenesis.

The Experiment of BMP-2 Combined with N-Ha/n-ldig Composites Repairing Radius Bone Defect in Rabbits

BMP-2 Plasmid DNA-loaded Chitosan Films – A New Strategy for Bone Engineering

BMP2 Gene Therapy on the Repair of Bone Defects of Aged Rats

Novel Strategies for Spatiotemporal and Controlled BMP-2 Delivery in Bone Tissue Engineering